載入...
Treatment of high-risk neuroblastoma
Although high-dose chemotherapy and autologous stem cell transplantation (HDCT/autoSCT) have improved the prognosis for patients with high-risk neuroblastoma (NB), event-free survival rates remain in the range of 30 to 40%, which is unsatisfactory. To further improve outcomes, several clinical trial...
Na minha lista:
| 主要作者: | |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Korean Pediatric Society
2012-04-01
|
| 叢編: | Korean Journal of Pediatrics |
| 主題: | |
| 在線閱讀: | http://kjp.or.kr/upload/pdf/kjped-55-115.pdf |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|